- Home
- MOGU vs QTTB Comparison
MOGU vs QTTB Comparison
Compare MOGU & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- QTTB
- Stock Information
- Founded
- MOGU 2011
- QTTB 2015
- Country
- MOGU China
- QTTB United States
- Employees
- MOGU N/A
- QTTB N/A
- Industry
- MOGU Business Services
- QTTB Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- QTTB Health Care
- Exchange
- MOGU Nasdaq
- QTTB Nasdaq
- Market Cap
- MOGU 17.8M
- QTTB 19.0M
- IPO Year
- MOGU 2018
- QTTB N/A
- Fundamental
- Price
- MOGU $2.29
- QTTB $1.65
- Analyst Decision
- MOGU
- QTTB Hold
- Analyst Count
- MOGU 0
- QTTB 8
- Target Price
- MOGU N/A
- QTTB $24.00
- AVG Volume (30 Days)
- MOGU 35.6K
- QTTB 185.5K
- Earning Date
- MOGU 07-08-2025
- QTTB 05-08-2025
- Dividend Yield
- MOGU N/A
- QTTB N/A
- EPS Growth
- MOGU N/A
- QTTB N/A
- EPS
- MOGU N/A
- QTTB N/A
- Revenue
- MOGU $19,801,126.00
- QTTB N/A
- Revenue This Year
- MOGU N/A
- QTTB N/A
- Revenue Next Year
- MOGU N/A
- QTTB N/A
- P/E Ratio
- MOGU N/A
- QTTB N/A
- Revenue Growth
- MOGU N/A
- QTTB N/A
- 52 Week Low
- MOGU $1.81
- QTTB $1.38
- 52 Week High
- MOGU $3.58
- QTTB $53.79
- Technical
- Relative Strength Index (RSI)
- MOGU 54.24
- QTTB 45.84
- Support Level
- MOGU $2.05
- QTTB $1.49
- Resistance Level
- MOGU $2.50
- QTTB $1.63
- Average True Range (ATR)
- MOGU 0.20
- QTTB 0.15
- MACD
- MOGU 0.02
- QTTB 0.02
- Stochastic Oscillator
- MOGU 68.66
- QTTB 38.94
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.